InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: Albino2 post# 33050

Thursday, 08/28/2014 8:21:03 AM

Thursday, August 28, 2014 8:21:03 AM

Post# of 427818
The R-IT study design is 5,2% event rate and 15% eff. It's not 100% clear for me that the 5,2% for the entire study or for the placebo (statin only) arm.
If it is for the entire study than the estimeted placebo arm's event rate is 5,62% as (5,62 + 5,62*(1-0,15))/2 = 5,2%.

They modified the TG criteria in May 2013 (min. from 150 to 200) due to lower than expected event rate.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News